Treatment of Bovine Tropical Theileriosis with Buparvaquone

Overview

Journal Trop Anim Health Prod

Publisher Springer

Specialties Tropical Medicine
Veterinary Medicine

Date 1990 Feb 1

PMID 2321263

Citations 2

Authors

N N Sharma

A K Mishra

Affiliations

Soon will be listed here.

Abstract

The antitheilerial activity of buparvaquone in crossbred male calves, experimentally infected with Theileria annulata (Izatnagar isolate) has been tested. Animals were treated intramuscularly at the dose rate of 2.5 mg/kg1 body weight. A single dose of the drug administered during the phase of ascending parasitaemia cured all the infected calves while all the untreated infected control calves died.

Citing Articles

Biogenic nanoporous silicon carrier improves the efficacy of buparvaquone against resistant visceral leishmaniasis.

Thapa R, Mondal S, Riikonen J, Rantanen J, Nakki S, Nissinen T PLoS Negl Trop Dis. 2021; 15(6):e0009533.

PMID: 34185780 PMC: 8274846. DOI: 10.1371/journal.pntd.0009533.

Curcumin induced oxidative stress causes autophagy and apoptosis in bovine leucocytes transformed by .

Araveti P, Srivastava A Cell Death Discov. 2019; 5:100.

PMID: 31231548 PMC: 6547749. DOI: 10.1038/s41420-019-0180-8.

References

Dhar S, Malhotra D, Bhushan C, Gautam O . Chemotherapy of Theileria annulata infection with buparvaquone. Vet Rec. 1986; 119(25-26):635-6. View

McHardy N, Wekesa L, Hudson A, RANDALL A . Antitheilerial activity of BW720C (buparvaquone): a comparison with parvaquone. Res Vet Sci. 1985; 39(1):29-33. View